Pharsight

Ulesfia patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6793931 SHIONOGI INC Ectoparasite asphyxiator compositions and methods for their applications
Jul, 2022

(1 year, 8 months ago)

US7294342 SHIONOGI INC Ectoparasite asphyxiator compositions and methods for their application
May, 2024

(a month from now)

Ulesfia is owned by Shionogi Inc.

Ulesfia contains Benzyl Alcohol.

Ulesfia has a total of 2 drug patents out of which 1 drug patent has expired.

Expired drug patents of Ulesfia are:

  • US6793931

Ulesfia was authorised for market use on 09 April, 2009.

Ulesfia is available in lotion;topical dosage forms.

Ulesfia can be used as topical treatment of lice infestations.

The generics of Ulesfia are possible to be released after 19 May, 2024.

Drugs and Companies using BENZYL ALCOHOL ingredient

Market Authorisation Date: 09 April, 2009

Treatment: Topical treatment of lice infestations

Dosage: LOTION;TOPICAL

How can I launch a generic of ULESFIA before it's drug patent expiration?
More Information on Dosage

ULESFIA family patents

Family Patents